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Abstract
Background:  Microarray technologies have evolved rapidly, enabling biologists to quantify
genome-wide levels of gene expression, alternative splicing, and sequence variations for a variety
of species. Analyzing and displaying these data present a significant challenge. Pathway-based
approaches for analyzing microarray data have proven useful for presenting data and for generating
testable hypotheses.
Results: To address the growing needs of the microarray community we have released version 2
of Gene Map Annotator and Pathway Profiler (GenMAPP), a new GenMAPP database schema, and
integrated resources for pathway analysis. We have redesigned the GenMAPP database to support
multiple gene annotations and species as well as custom species database creation for a potentially
unlimited number of species. We have expanded our pathway resources by utilizing homology
information to translate pathway content between species and extending existing pathways with
data derived from conserved protein interactions and coexpression. We have implemented a new
mode of data visualization to support analysis of complex data, including time-course, single
nucleotide polymorphism (SNP), and splicing. GenMAPP version 2 also offers innovative ways to
display and share data by incorporating HTML export of analyses for entire sets of pathways as
organized web pages.
Conclusion: GenMAPP version 2 provides a means to rapidly interrogate complex experimental
data for pathway-level changes in a diverse range of organisms.
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Background
Advances in DNA microarrays, RNA interference, and
genome-wide gene engineering have contributed a wealth
of genomic data to the public domain. The average
researcher is faced with the challenge of connecting these
genome level results to specific biological processes.
Therefore intuitive tools for integrating, analyzing, and
displaying this data are welcomed by many biologists.
One popular approach is pathway-oriented data analysis,
which enables biologists to interpret genomic data in the
framework of biological processes and systems, rather
than in a traditional gene-centric manner.
We developed Gene Map Annotator and Pathway Profiler
(GenMAPP) as a free, open-source, stand-alone computer
program for organizing, analyzing, and sharing genome-
scale data in the context of biological pathways [1]. Gen-
MAPP was initially released in 2001 and has been widely
used with over 15,000 unique user registrations and over
250 publications citing its use. GenMAPP allows users to
view and analyze genome-scale data, such as microarray
data, on biological pathways, Gene Ontology terms or any
other desired grouping of genes. These groupings are rep-
resented and stored in GenMAPP as "MAPPs". GenMAPP
automatically and dynamically colors genes on MAPPs
according to data and criteria supplied by the user. In
addition, GenMAPP allows investigators to easily access
annotation for genes at major genomic databases, such as
Ensembl [2], Entrez Gene [3], and Gene Ontology (GO)
[4]. Using the integrated MAPPFinder tool, researchers
can rapidly explore their data in the context of pathways
and the GO hierarchy by over-representation analysis [5].
GenMAPP was developed by biologists and remains
focused on pathway visualization for bench biologists,
our major user base as judged from publications citing
GenMAPP. Unlike other computational systems biology
tools (e.g., BioSPICE [6], CellDesigner [7], E-Cell [8]),
GenMAPP is not designed for cell/systems modeling.
GenMAPP focuses on the immediate needs of bench biol-
ogists by enabling them to rapidly interpret genomic data
with an intuitive, easy-to-use interface.
Implementation
GenMAPP is implemented in Visual Basic 6.0 and is avail-
able as a stand-alone application for Windows operating
systems [1]. The program includes an automatic update
feature that allows rapid and reliable updates to the pro-
gram and documentation.
The three main data components in GenMAPP – experi-
mental data (.gex), gene databases (.gdb), and pathways
(.mapp) – are stored in separate files accessible by Gen-
MAPP. All three file types are stored in Microsoft Jet for-
mat. Experimental datasets store any data imported by the
user, together with a set of custom coloring criteria (color
sets). The gene databases contain species-specific gene
annotation from a number of public resources. Databases
are created through an ETL (Extract, Transform, and Load)
process, by which information is collected from Ensembl,
Entrez Gene, Affymetrix [9], and GOA (UniProt) [10] and
reassembled. Annotations supported by GenMAPP
include Ensembl gene IDs, UniProt IDs, Entrez Gene IDs,
Gene Symbols, UniGene IDs, RefSeq protein IDs, HUGO
IDs, GO terms, Affymetrix probe set IDs, RGD IDs (rat),
MGI IDs (mouse), SGD IDs (yeast), FlyBase IDs (fruit fly),
WormBase IDs (worm), ZFIN IDs (zebrafish), InterPro
IDs, EMBL IDs, PDB IDs, OMIM disease associations, and
Pfam IDs. MAPPs contain a set of gene or protein identifi-
ers as well as optional graphical elements which are laid
out manually. It is up to the author of the MAPP to choose
how to illustrate activation, inhibition, compartments,
etc. There is no graph underlying MAPPs, there are no for-
mal nodes and edges: the gene boxes are data-linked, but
all lines, edges and sub-groupings are illustrations only.
Each MAPP can also contain a record of the author and
any relevant literature references. GenMAPP does not
restrict users to particular semantics. A MAPP can repre-
sent any gene set whether it is a metabolic pathway, a sig-
naling pathway, a disease process or an arbitrary set. The
pathway archives GenMAPP distributes undergo general
review and revision by the GenMAPP staff.
Databases and pathway archives are available through the
Data Acquisition Tool in GenMAPP and from the Gen-
MAPP website. The tools known as MAPPFinder 2 and
MAPPBuilder 2 are bundled with and accessible from
GenMAPP. MAPPBuilder creates .mapp files from
imported lists of genes, and MAPPFinder [5] computes
permutation test P values for over-representation of differ-
entially expressed genes in individual GO categories and
MAPPs. Westfall-Young adjusted P values [11] are
included as a control for multiple testing.
Results and discussion
GenMAPP version 2 provides 1) new built-in features to
support user data import and mapping, 2) expanded
pathway resources and 3) increased support for different
high-throughput biological assays. These improvements
substantially increase the usability and flexibility of this
tool for pathway level genomic analysis.
GenMAPP version 2 new features
Several new features have been implemented in Gen-
MAPP version 2. A new gene database schema supports a
variety of gene and protein identifiers, annotations, and
microarray probe set IDs, more thoroughly connecting
user data to the archive of pathway MAPPs and Gene
Ontology terms and to external gene annotation. A new
visualization mode allows for simultaneous access toBMC Bioinformatics 2007, 8:217 http://www.biomedcentral.com/1471-2105/8/217
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multiple data points, statistics or custom annotations. A
new export option packages sets of pathways, including
data, to a web-ready format for display and browsing.
Expanded gene and species support in GenMAPP version 2
A major shortcoming of GenMAPP 1.0 and other pathway
analysis programs has been the limited number of species
supported, permitting analysis of a few model organisms
(human, mouse, rat, and yeast) and a few gene identifier
or ID systems (GenBank, SGD, and UniProt). To solve this
problem, the GenMAPP version 2 gene database schema
has been redesigned to allow expanded gene content and
greater species support. Support of many diverse gene and
protein ID systems is essential to establish critical rela-
tionships between disparate sources of information, pro-
viding greater flexibility for users importing data
associated with virtually any identifier. In addition to
expanded gene and protein ID support, secondary anno-
tation systems such as GO, OMIM, and PDB have been
added into the GenMAPP gene databases. These IDs and
annotations are provided on HTML "backpages" of MAPP
gene objects, providing critical links to primary resources.
As additional genomes are assembled and annotated,
GenMAPP can readily integrate the information and sup-
port pathway analysis for these species.
Databases in GenMAPP version 2 are created through a
semi-automated process, using information extracted
from major public resources, primarily Ensembl, Entrez
Gene, UniProt, and Affymetrix. The process of extracting
gene information has been greatly simplified by populat-
ing our gene database with data from Ensembl's "mart"
tables [12], which effectively integrates gene information
for major sequenced genomes. GenMAPP.org currently
distributes databases for eleven species: human, mouse,
rat, yeast, worm, zebrafish, fruit fly, mosquito, chicken,
dog, and cow. GenMAPP version 2 also supports user-
defined additions to these databases as well as the crea-
tion of custom gene databases for any other species. The
ability to create custom databases is of vital importance to
research groups working with model organisms not sup-
ported by the major public databases. This feature is sup-
ported by only one other pathway analysis tool we are
aware of [13]. Creating a custom database is a collabora-
tive effort where GenMAPP developers generate a tem-
plate database containing relevant GO term associations
for the species of interest. A user interface within Gen-
MAPP version 2 allows users to add to the template data-
base by importing additional gene and annotation
information as a set of relational tables. The build process
can be completed entirely using GenMAPP and common
spreadsheet programs (e.g., Excel), without the need for
specialized database software. The resulting database has
full GenMAPP functionality, including the ability to dis-
play information on HTML backpages, link to external
sources, and perform global GO queries using MAPP-
Finder. Custom GenMAPP version 2 databases are cur-
rently available for Escherichia coli K12 (KDD and John
David N. Dionisio, personal communication) and Saccha-
romyces pombe [14]. A detailed manual describing the
process of creating a custom gene database is available at
GenMAPP.org.
Visualizing complex genomic data
As microarray experimental designs grow increasingly
complex researchers require tools to examine data across
multiple time-points and conditions, and over multiple
datasets. The types of biological entities measured have
also increased. Various array platforms measure polymor-
phisms, splice variants, regulatory protein binding and
genomic amplifications and deletions. Methods for visu-
alizing the complex outputs from these technologies have
not been well established and remain a critical challenge
for researchers. With previous versions of GenMAPP, users
could view multiple sets of criteria only serially. For exam-
ple, genes up-regulated at different time-points of an
experiment could be viewed by creating a custom set of
coloring criteria (color set) for each time point. While
informative, this method is not well suited to assess the
temporal effects of gene level changes over an extended
time or to examine multiple data simultaneously. To
expedite the analysis of such datasets, GenMAPP version
2 now allows multiple color sets to be viewed simultane-
ously, depicted as vertical stripes within each gene box. In
the case of multiple time points, the stripes could repre-
sent the criteria at each time point.
The ability to view multiple color sets concurrently can
also be extended to datasets where different biological
substrates are examined, such as transcription and mRNA
splicing. Demand for this feature is increasing because
current microarrays can assay distinct regions of mRNA
transcripts, such as exons and exon junctions, thereby
allowing assessment of both transcriptional changes and
changes in splice isoform expression. While there are
many possible ways to view such data, using multiple
color sets in GenMAPP is now a powerful way to explore
such complex data in a single view. Similar visualization
options are only available in a few freely available [15]
and commercial applications [16,17].
Batch export of data to the web
In addition to visualizing data on pathway MAPPs, Gen-
MAPP version 2 also exports pathways with data to vari-
ous graphical formats and to the web. Because genome-
scale data are difficult to share with a larger community,
GenMAPP version 2 includes the option to export any
number of MAPPs with their associated data to an organ-
ized web-ready format. This MAPP Set Export feature
allows any or all established color sets to be exported withBMC Bioinformatics 2007, 8:217 http://www.biomedcentral.com/1471-2105/8/217
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the pathway, including the striped view of multiple color
sets. Instead of static images, each MAPP retains its inter-
active features, such as gene backpage information,
including data display, gene annotations, and hyperlinks
to external resources. The different criteria can be browsed
through a pull-down tab on each exported MAPP. The
MAPP Set can be navigated through an index of all MAPPs
or through a gene index, which stores all gene-to-MAPP
relationships for all related gene/protein IDs. MAPP Sets
are stored in HTML format, ready for immediately posting
on any web site, where collaborators can browse the data
independently of the GenMAPP program. An example of
how a GenMAPP MAPP Set can be used to display large-
scale data is the International Gene Trap Consortium web
site [18], where thousands of publicly available gene trap
ES cell lines can be viewed in the context of biological
pathways [19]. This method of data presentation allows
users to quickly share information over the Internet and
perform efficient searches for gene pathway information.
Batch export of fully interactive pathways and user data is
not available in other pathway analysis tools we are aware
of.
New Pathway Resources
Integral to any pathway analysis tool is its access to path-
way content. One of the goals of the GenMAPP project is
to facilitate community curation of pathway content.
GenMAPP's built-in drawing tool allows users to illustrate
biology and associate gene objects with identifiers main-
tained in a given gene database. The ability to customize
the layout and to annotate a pathway with basic graphics
provides a powerful means of communication to the bio-
logical community. The expertise of the biological
research community is the most important source of new
pathway information, and GenMAPP's pathway content is
primarily contributed by this community. We have added
several new sources of MAPPs. For example the NetPath
project is a human pathway annotation project, initiated
by the Pandey lab at Johns Hopkins University [20,21]
and the Institute of Bioinformatics [22]. The NetPath
group has produced 10 cancer and 10 immune pathways
in GenMAPP, BioPAX [23], and PSI-MI [24] formats, and
are planning a substantial increase within the first year.
Another ongoing pathway curation effort is being per-
formed by undergraduate research students directed by
Dr. Kam Dahlquist. These students have contributed 120
yeast pathways that were created by hand using the SGD
BioCyc metabolic pathways [25] as templates. The Gen-
MAPP pathway archives also include selected content
from KEGG [26], Reactome [27,28], The European
Nutrigenomics Organization [29], Neurocrine Bio-
sciences, PharmGKB [30], and various academic laborato-
ries. The content from these resources was manually
migrated by the MAPP authors with the exception of the
"KEGG Converted" archive, which is not updated or syn-
chronized. The pathways from community resources are
collected and organized at GenMAPP.org and automati-
cally downloadable through the GenMAPP program.
We now also provide pathways that have been mapped
through homology so that users with genomic data from
relatively unsupported species can perform pathway anal-
yses. These homology MAPPs represent a starting point
for further curation, an interim solution until species-spe-
cific pathways are elucidated and contributed. Another
means of increasing the biological content available to the
user is the extension of existing pathways using interac-
tion and coexpression data. Together, these methods only
begin to address the paucity of pathway content available
for the analysis of complex genomics data across the mul-
titude of organisms.
Making homology MAPPs
Despite the relative ease with which we can gather gene
information for many species, pathway information is
generally not available for many of the newly supported
species (Table 1). To address this problem, we imple-
mented a strategy that utilizes the existing pathway con-
tent in our pathway archives. Using publicly available
gene homology information [12,31], we generated path-
ways for several species from our archive of existing
human pathways (Figure 1).
The process of rapidly mapping pathways between species
relies on the Converter function in GenMAPP version 2,
which allows for conversion of genes on MAPPs between
gene ID systems in the database without altering the
graphical layout of the MAPP. MAPP conversion is possi-
ble between any gene ID systems linked in the database;
adding homology information to a GenMAPP database
consequently enables conversion of MAPPs between spe-
cies.
The GenMAPP human MAPPs were chosen as template
MAPPs because they represent the highest quality of cura-
tion in our archive. Homology information between
human and the applicable target species was obtained
from Homologene [31] and from EnsMart [22] (for cow
only)(Algorithm details in Supplemental Data). For sim-
plicity we restricted the use of data from these resources to
1:1 gene relationships between template and target spe-
cies. This restriction reduces clutter in the converted
MAPPs and avoids potentially ambiguous homology rela-
tionships. Conversion rates (percentage of genes con-
verted) were calculated for each pathway MAPP (Figure 2
and Supplemental Data). To maintain reasonable gene
content on MAPPs, a cutoff of 50% for the conversion rate
was set for inclusion in the MAPP archives. The cutoff of
50% was chosen based on the qualitative assessment of
structure and pathway information retained followingBMC Bioinformatics 2007, 8:217 http://www.biomedcentral.com/1471-2105/8/217
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conversion (see supplemental data for MAPP conversion
rates). Qualitatively, the conversion rates correlated with
the expected conservation of biological processes across
species. The MAPPs representing the central dogma of
DNA replication, RNA transcription and translation, for
example, were converted with high fidelity from human
to each of the target species, whereas specialized signaling
pathways failed to be translated beyond dog, cow and
chicken. This strategy of utilizing public homology infor-
mation, existing pathway information and the Converter
function can be applied to any species with available
homology information to a species for which pathway
information exists. Instructions for translating MAPPs
between species using the GenMAPP Converter is availa-
ble at GenMAPP.org [32].
The development of homology MAPPs in GenMAPP
builds upon similar efforts at other databases [27] and
addresses the dearth of pathway content that can be que-
ried computationally. However, it is important to note
that these MAPPs are not genuine species-specific path-
ways, but rather translations of human pathways where
target species genes have been mapped based on homol-
ogy. This distinction is important since accurate pathway
inference requires knowledge that the particular biologi-
cal process and molecular interactions are conserved
between organisms and that predicted homologues
encode for gene products that perform the same biologi-
cal function. Another current limitation is that, unlike sev-
eral other resources [27,33,34], the reactions in a
GenMAPP pathway are illustrations rather than computa-
ble networks that allow for identification of conserved
interactions. Furthermore, pathways for non-mammalian
species are mapped from human rather than the most
closely related organism. As such, these homology MAPPs
are by no means equal to the quality of manually curated
MAPPs. For that reason homology MAPPs are distributed
as a separate archive, accompanied by a README file
explaining the nature of these MAPPs. They nonetheless
offer an immediate and concrete solution for many
researchers studying organisms with minimally annotated
genomes not supported by other analysis programs. It is
our hope that these pathways will serve to nucleate addi-
tional curated pathways. Furthermore, the information
provided by pathway representations of known biology,
especially for minimally annotated genomes, is crucial
not only for analyzing large-scale datasets, but also for
assigning gene function.
Extending pathways
The use of homology mapping addresses the critical need
to extend biological representations across species. Yet it
is also necessary to expand the pathway content within a
given species. In the case of mammalian model organ-
isms, such as mouse, only ~14% of annotated genes in the
genome are represented in curated pathways (from the
combined archives of GenMAPP, KEGG, BioCarta [35]
and Reactome). Figure 3 illustrates the collection of
curated pathways in the GenMAPP archive over time,
which, in terms of gene content is >90% redundant with
BioCarta and Reactome. The collection of curated path-
ways from the scientific community is a slow, iterative
process that requires the synthesis of a variety of evidence.
Such evidence is being cataloged in numerous databases
as protein-protein interactions, genetic interactions, and
coexpression patterns, which are rapidly expanding with
the advent of large-scale, high-throughput assays. But it
remains a challenge to form meaningful networks from
this data and grow our understanding of pathways.
To address this challenge, we created a new pathway
resource, which incorporates additional genes into our
existing set of pathways using prior evidence. This method
of pathway extension has been previously used to include
new genes predicted to expand and enhance the content
of existing pathways and gene sets [36]. The method can
work with any type of data that can be modeled as pairs of
linked genes. The most obvious example is protein-pro-
tein interactions, where the link between genes represents
the physical association of two proteins. The link could
also represent coexpression, transcriptional regulation, or
literature search results. The extension method is currently
implemented as a set of in-house Perl scripts used as an
accessory to GenMAPP to expand a given pathway. Each
pathway MAPP is processed individually. First, the gene
IDs are extracted from the pathway and converted to a
uniform ID system (e.g., Entrez Gene). The resulting gene
list is used to query one or more specified databases (e.g.,
protein-protein interactions). A threshold is set for includ-
ing new genes (e.g., one or more links to original gene
list). Finally, the new genes are added to a side panel of
the original MAPP, separate from the curated pathway,
and the interaction partners are noted and stored in the
remarks field of each involved gene (Figure 4).
Using this approach, we extended the GenMAPP curated
pathway archives for mouse with two types of data: pro-
tein-protein interactions and coexpression data [37] (see
supplemental data). The coexpression links were derived
from a network analysis of correlated gene expression
across multiple species networks [37] under the premise
that genes that maintain an evolutionary conservation of
coregulation often participate in a related biological proc-
ess [38,39]. With the additional genes added from these
datasets, we have significantly increased the coverage
(~25%) per genome (Figure 3). It is important to distin-
guish the added genes from those originally in the path-
way since the added genes are not necessarily involved in
the pathway; rather, they are related to the pathway by a
particular type of evidence. Having access to this relatedBMC Bioinformatics 2007, 8:217 http://www.biomedcentral.com/1471-2105/8/217
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information in the same view as the pathway allows for
simultaneous data visualization and statistical analysis
using MAPPFinder. These extended pathways may also
serve as launching points for improved pathway curation
by the community and as a predictive method for identi-
fying new pathway interactions.
The WNT-signaling pathway is shown in GenMAPP for human and dog (left to right) Figure 1
The WNT-signaling pathway is shown in GenMAPP for human and dog (left to right). The dog pathway MAPP was mapped 
from the original curated human pathway MAPP by using homology information from Homologene and Ensembl. Additional 
information in the top-left corner of the MAPP indicates the origin.
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Table 1: Number of GenMAPP MAPPs for GenMAPP supported species
Species Contributed Homology KEGG Converted
Human 109
Mouse 109
Rat 100
Dog 94
Cow 87
Chicken 85
Zebrafish 19 18
Fruit fly 2 25 89
Worm 19 87
Yeast 122* 9
Column Headers: Contributed: MAPPs contributed to the GenMAPP project. Homology: MAPPs mapped from human pathways using homology 
information. KEGG Converted: MAPPs automatically created from the KEGG resource. Note: *Includes 120 SGD metabolic MAPPs contributed by 
undergraduate research students mentored by Dr. Kam Dahlquist.BMC Bioinformatics 2007, 8:217 http://www.biomedcentral.com/1471-2105/8/217
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Examples of pathway analysis
Here we explore three of the many examples of how Gen-
MAPP version 2 can be used to analyze data from complex
genomic experiments and the types of biological insights
potentially gained.
Gene expression time course analysis
In figure 5, we display gene expression data from multiple
time-point comparisons for the myometrium during ges-
tation [40]. There are two baselines in this analysis: virgin
non-pregnant (NP) myometrium and mid-pregnancy
myometrium. The comparison allows the user to simulta-
neously examine the effects of pregnancy as compared to
non-pregnant animals and the specific temporal effects
leading up to labor through postpartum.
The prostaglandin synthesis and regulation pathway con-
tains molecular interactions that are critical in the transi-
tion of the myometrium from a relatively quiescent tissue
throughout pregnancy to a highly contractile tissue at
term. By viewing multiple time-point comparisons in this
pathway, one can easily see which genes are differentially
expressed just prior to the onset of labor (18 days of preg-
nancy) compared to mid-pregnancy (14 days of preg-
nancy) (e.g. Ptgs2, Edn1 and Hsd11b1) alongside the
relative expression of these genes at mid-pregnancy versus
the virgin state (first stripe). Making such comparisons in
the new version of GenMAPP is relatively straightforward
and flexible, supporting not only multiple data points,
but also multiple types of data (see SNP example, figure
6c). In GenMAPP version 2, the user can also select any
combination of color sets to view on a given MAPP simply
by selecting them from the "Choose Color Set" pull-
down.
Analysis of whole-genome exon array data
As the feature size of DNA microarrays have decreased, the
number of probes hybridizing to specific targets has
increased by well over an order of magnitude. In the
example shown in Figure 6a, we examined a publicly
available microarray dataset that measured the expression
of all known and predicted exons from 11 different adult
human tissues [41]. From these data, both gene expres-
sion changes between tissues and splicing scores can be
calculated for all genes (see supplemental methods). Gen-
MAPP version 2 can display this information in each gene
box, with the central color stripes indicating relative
expression change for each tissue (red or blue) and the
Conversion rate (percentage of genes converted) for MAPPs in the Cellular Process category of the Contributed archives Figure 2
Conversion rate (percentage of genes converted) for MAPPs in the Cellular Process category of the Contributed archives. 
Colored lines indicate conversions per species; dashed line indicates the 50% cutoff for inclusion in the Homology MAPPs 
archive. As expected, highly conserved processes showed high conversion rates across species (far left), while more specialized 
processes were homologous only among more closely related species.
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rim color designating a threshold for the significance of an
alternative splicing call (green, gray, or white). This strat-
egy takes advantage of how GenMAPP prioritizes assign-
ment of central and rim colors of a gene box based on the
order of the underlying data. Viewing related identifiers to
a given gene as a secondary rim criterion can provide crit-
ical information to the analysis and is a unique feature of
GenMAPP. When viewed in the context of Monoamine G-
protein coupled receptors, we can clearly identify in which
tissues a gene is most highly expressed (bright red center
color) and which genes have a significant alternative splic-
ing call (green rim color). By creating a color set for each
of the 11 tissues and selecting "all" for visualization, both
the tissue specific regulation of gene expression and the
likelihood of splicing can be assessed in a single view. The
results from this dataset can be exported for any given set
of pathways with web-ready images and HTML backpages
for each and every gene. The web export function allows
researchers to navigate and effectively communicate the
impact of both gene expression and splicing on specific
pathways and genes (see the GenMAPP website [42] for
this example and others).
Combining proteomic and gene expression data
In another example, gene expression and proteomic data
[43] is viewed concurrently as two adjacent stripes of color
(Figure 6b). The example displays data from an experi-
ment measuring both mRNA and protein levels in yeast in
response to changes in carbon source. Simultaneously vis-
ualizing changes at the transcript and protein level in the
context of pathways represents a more informative depic-
tion of the system-level changes occurring in the organism
than if either data was analyzed alone. The flexibility of
combining any number of disparate data types in a single
view is a relatively uncommon feature in pathway analysis
tools. To view two data types side by side, datasets are
combined into a single spreadsheet before import into
GenMAPP. There are no restrictions on the nature of data
that can be viewed as independent, adjacent color sets,
provided that the data links to the GenMAPP gene data-
base.
Integrating genomic, phenotypic and structural 
information for polymorphism data
One of the key principles of pathway analysis is the inte-
gration of multiple pieces of information in order to
assess new data in the context of known biology. In stud-
ying polymorphic, or SNP, differences that may contrib-
ute to disease, the ability to compare the distribution of
polymorphisms in the population along with phenotypic
and protein product effects in the context of biological
pathways provides both a birds-eye view and detailed dis-
Number of mouse genes represented on GenMAPP Pathways and in Gene Ontology Figure 3
Number of mouse genes represented on GenMAPP Pathways and in Gene Ontology. The unique gene content in the Gen-
MAPP pathway archive is traced over time (blue) for the mouse genome in terms of the number of genes (left axis) and corre-
sponding percentage of the genome (right axis). For comparison, the unique gene content annotated by Gene Ontology is 
shown (green). Significant gains in absolute gene content were made by collecting new pathways targeting new biology (e.g., 
NetPath) and by extending pathways with orthogonal datasets from coexpression and protein-protein interaction networks 
(latest GenMAPP count at 7095 genes, or ~25% of the genome).
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section of how specific changes might impact larger bio-
logical systems. An example of how these different types
of biological data can be combined is shown in Figure 6c
using data from a whole-genome myocardial infarction
SNP array experiment [44]. Displaying data in this format
highlights genes evidenced by association, experimental
and bioinformatics predictions (e.g. CETP, MTP) as well
as their relationship to each other and with other genes
upstream and downstream of these components. Display
formats such as this allow access to multiple modes of
gene regulation from a single display.
Although these examples illustrate three possible meth-
ods for displaying complex results, users can customize
such views and apply them to any combination of data
types that have been merged and ordered before import to
GenMAPP. This feature provides a means to assess multi-
ple modes of gene regulation and thus new avenues of
insight into complex biological relationships.
Ongoing development of GenMAPP
GenMAPP version 2 provides new tools for analyzing
complex data in the context of biological pathways for a
variety of genomes. Although the new features of Gen-
MAPP version 2 are a useful starting point for the analysis
of complex microarray data, there are still a number of
obstacles to overcome. These obstacles include providing
cross-platform tools for integrating pathway resources,
representing gene features (such as SNPs and splicing var-
iation), and supporting structured pathway vocabularies
for more efficient pathway migration, update, curation
and exchange.
To accelerate development and take full advantage of the
growing base of open source pathway tools we are actively
working with the Cytoscape Consortium [45,46] and Bio-
PAX [23] developers to implement GenMAPP-style visual-
ization and analysis methods in a new software
framework. The primary aims are (1) to transition to a
platform-independent Java code base that is readily inte-
grated with online resources, (2) to support dynamically
generated gene databases that not only organize identifi-
ers and aliases, but also sub-gene entities such as tran-
scripts, exons, and polymorphisms, and (3) to provide
innovative analysis tools to preprocesses high-throughput
datasets preparing them for integration with gene data-
bases and statistical analyses, as well as for abstracted vis-
ualization at multiple levels of resolution. We are also
working on an XML-based pathway data format that cap-
tures relationships, coordinates, and annotations, as well
as a Web tool that facilitates pathway content migration,
and curation from the community. We anticipate that
open source bioinformatics tools such as GenMAPP and
Cytoscape will provide researchers with a new view of
biology that integrates genomic data with our growing
knowledgebase of pathways.
G1 to S cell-cycle control pathway extended with genes from a coexpression network Figure 4
G1 to S cell-cycle control pathway extended with genes from a coexpression network. All genes assigned to the original path-
way were queried against the coexpression network. Yellow designates the genes found in the coexpression network and blue 
designates their coexpression partners that were extracted from the network and added to the pathway.
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Conclusion
GenMAPP version 2 represents a step towards fostering
the critical link between the biologist and their data, pro-
viding powerful analyses and intuitive representations of
increasingly large and complex high-throughput datasets.
Availability and requirements
Project Name: GenMAPP
Project Home Page: http://www.genmapp.org
Operating System: Windows
Programming Language: Visual Basic
Requirements: Species-specific databases and pathway file
collections distributed by GenMAPP.org
License: Open-source (Apache)
Any Restrictions to Use by Non-academics: None
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Striped view of multiple time-point comparisons Figure 5
Striped view of multiple time-point comparisons. Gene expression data from mouse uterine smooth muscle from mid-to-late 
pregnancy through postpartum are shown as striped color sets on a pathway for prostaglandin synthesis and regulation. For 
each comparison, a separate color set was generated, with eight colors designating different fold thresholds. The order of the 
criteria dictates the priority for how a gene box is colored. For this dataset, the striped view allows comparison of expression 
changes that are predicted to promote versus block contraction during distinct phases of pregnancy. Multiple probe sets from 
the microarray linking to a gene are indicated by a dashed edge around the gene box. The central color of the gene box corre-
sponds to the predominant criterion met (mode) and the rim colors represent the second most prevalent criterion met.
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Striped view of multiple data types Figure 6
Striped view of multiple data types. (A) Transcription and splicing data, collected on whole-genome exon tiling microarrays 
(see supplemental methods), are represented by stripes of color on a functionally organized list of monoamine G-protein-cou-
pled receptors. Transcriptional changes for 11 different human tissues are displayed as the center color of the gene box, and 
splicing for the gene across all tissues is displayed as the rim color. (B) In the context of glycolysis and gluconeogenesis, mRNA 
and protein levels change in response to carbon source perturbation in Saccharomyces cerevisiae growing on galactose or etha-
nol. The color on the left side of the gene box illustrates mRNA changes; the color on the right indicates corresponding pro-
tein-level changes. (C) A variety of SNP parameters can be viewed simultaneously using the striped view. SNP distribution 
(dbSNP http://www.ncbi.nih.gov/SNP), structure-based functional predictions (LS-SNP http://alto.compbio.ucsf.edu/LS-SNP/), 
and myocardial infarction (MI) association data are combined to asses the coverage of the SNP panel over a pathway depicting 
the role of statin drugs. To view the complete versions of these MAPPs with live backpages see Supplemental Data.
Adrenergic Histamine
Receptors
ADRA1A
ADRA1B
ADRA1D
ADRA2A
ADRA2B
ADRA2C
ADRB1
ADRB2
ADRB3
HRH1
HRH2
Receptors
Expression Dataset 
Color Sets:
Breast
Cerebellum
Heart
Kidney
Liver
Muscle
Pancreas
Prostate
Spleen
Testes
Thyroid
Gene
Legend:
Center - Up regulated > 2-fold 
Center - Down regulated > 2-fold 
Rim - Predicted alternatively spliced 
Rim - Not alternatively spliced 
Rim - Splicing not evaluated 
Center - Not regulated 
Monoamine GPCRs 
Cell Membrane 
Statin
HMGCR
CYP7A1
SOAT1
MTP
DGAT1
AcetylCoA Cholesterol
Cholic Acid 
Free FA 
Cholesterol Ester 
Phospholipid
Triglycerides
Liver Cell 
LDLR SCARB1 LRP1
LPL LIPC
CETP
APOC1
APOE APOC2
APOC3
LDL IDL VLDL
HDL
PON1 PON2
PON3
Expression Dataset 
Color Sets:
At ligand interface 
Destabilizes protein 
Associated with MI 
Gene
Legend: At ligand interface 
SNP at ligand or domain interface 
No effect 
No criteria met 
Legend: Destablizes protein 
SNP destabilizes protein structure 
No effect 
No criteria met 
Legend: Associated with MI 
SNP associated with MI 
No effect 
No criteria met 
Statin Pathway (PharmGKB)
A 
C
Gq Pathway  Gi/o Pathway  Gs Pathway 
Glucose
Fructose-1,6-bisphosphate
Fructose-6-phosphate
Glucose-6-phosphate
Glycolysis
Gluconeogenesis
HXK1
GLK1 
HXK2 
PFK2
PFK1
PGI1
FBP1
Expression Dataset
Color Sets:
mRNA
protein ratio
Gene
Legend: mRNA
mRNA > 0.1
mRNA < -0.1
No criteria met
Not found
Legend: protein ratio
protein > 0.1
protein < -0.1
No criteria met
Not found
Glycolysis and Gluconeogenesis  B
Repression
Generic Route BMC Bioinformatics 2007, 8:217 http://www.biomedcentral.com/1471-2105/8/217
Page 12 of 12
(page number not for citation purposes)
grant HL66621 (to BRC). ARP was supported by the David R. and Mary 
Phillips Distinguished Postdoctoral Fellowship.
References
1. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR:
GenMAPP, a new tool for viewing and analyzing microarray
data on biological pathways.  Nat Genet 2002, 31(1):19-20.
2. Ensembl Genome Browser   [http://www.ensembl.org]
3. Entrez PubMed   [http://www.ncbi.nlm.nih.gov/entrez]
4. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM,
Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-
Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M,
Rubin GM, Sherlock G: Gene Ontology: Tool for the unification
of biology.  Nat Genet 2000, 25:25–29.
5. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC,
Conklin BR: MAPPFinder: Using Gene Ontology and Gen-
MAPP to create a global gene-expression profile from
microarray data.  Genome Biol 2003, 4:R7–R7.12.
6. Kumar SP, Feidler JC: BioSPICE: a computational infrastruc-
ture for integrative biology.  Omics 2003, 7:225.
7. Kitano H, Funahashi A, Matsuoka Y, Oda K: Using process dia-
grams for the graphical representation of biological net-
works.  Nat Biotechnol 2005, 23:961-966.
8. Tomita M, Hashimoto K, Takahashi K, Shimizu T, Matsuzaki Y, Miy-
oshi F, Saito K, Tanida S, Yugi K, Venter JC, Hutchison CA: E-CELL:
Software Environment for Whole Cell Simulation.  Genome
Inform Ser Workshop Genome Inform 1997, 8:147-155.
9. Affymetrix   [http://www.affymetrix.com]
10. Welcome to UniProt-UniProt [the Universal Protein
Resource]   [http://www.pir.uniprot.org]
11. Westfall PH, Young SS: Resampling-based multiple testing:
examples and methods for p-value adjustment.  Wiley series
in probability and mathematical statistics edition. New York, Wiley;
1993. 
12. Kasprzyk A, Keefe D, Smedley D, London D, Spooner W, Melsopp C,
Hammond M, Rocca-Serra P, Cox T, Birney E: EnsMart: a generic
system for fast and flexible access to biological data.  Genome
Res 2004, 14:160-169.
13. Hu Z, Mellor J, Wu J, Yamada T, Holloway D, Delisi C: VisANT:
data-integrating visual framework for biological networks
and modules.  Nucleic Acids Res 2005, 33:W352-7.
14.    [http://www.databases.niper.ac.in/Pombe/]. S.pombe gene database
for GenMAPP
15. Yi M, Horton JD, Cohen JC, Hobbs HH, Stephens RM: WholePath-
wayScope: a comprehensive pathway-based analysis tool for
high-throughput data.  BMC Bioinformatics 2006, 7:30.
16. Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T: Pathway
mapping tools for analysis of high content data.  Methods Mol
Biol 2007, 356:319-350.
17. Chu L, Scharf E, Kondo T: GeneSpring: Tools for Analyzing
Microarray Expression Data.  Genome Informatics 2001,
12:227-229.
18. IGTC, International Gene Trap Consortium   [http://www.gen
etrap.org]
19. IGTC, International Gene Trap Consortium   [http://www.gen
etrap.org/dataaccess/pathways.html]
20. NetPath - Signal Transduction Pathways   [http://www.net
path.org]
21. Pandey Lab   [http://pandeylab.igm.jhmi.edu]
22. Institute of Bioinformatics   [http://www.ibioinformatics.org]
23. BioPAX Home   [http://www.biopax.org]
24. Hermjakob H, Montecchi-Palazzi L, Bader G, Wojcik J, Salwinski L,
Ceol A, Moore S, Orchard S, Sarkans U, von Mering C, Roechert B,
Poux S, Jung E, Mersch H, Kersey P, Lappe M, Li Y, Zeng R, Rana D,
Nikolski M, Husi H, Brun C, Shanker K, Grant SG, Sander C, Bork P,
Zhu W, Pandey A, Brazma A, Jacq B, Vidal M, Sherman D, Legrain P,
Cesareni G, Xenarios I, Eisenberg D, Steipe B, Hogue C, Apweiler R:
The HUPO PSI's molecular interaction format--a commu-
nity standard for the representation of protein interaction
data.  Nat Biotechnol 2004, 22:177-183.
25. Yeast Biochemical Pathways   [http://pathway.yeastgenome.org/
biocyc/]
26. Kanehisa M, Goto S: KEGG: Kyoto encyclopedia of genes and
genomes.  Nucleic Acids Res 2000, 28:27–30.
27. Vastrik I, D'Eustachio P, Schmidt E, Joshi-Tope G, Gopinath G, Croft
D, de Bono B, Gillespie M, Jassal B, Lewis S, Matthews L, Wu G, Bir-
ney E, Stein L: Reactome: a knowledgebase of biological path-
ways and processes.  Genome Biol 2007, 8:R39.
28. Joshi-Tope G, Gillespie M, Vastrik I, D'Eustachio P, Schmidt E, de
Bono B, Jassal B, Gopinath GR, Wu GR, Matthews L, Lewis S, Birney
E, Stein L: Reactome: a knowledgebase of biological pathways.
Nucleic Acids Res 2005, 33:D428-32.
29. BiGCaT Bioinformatics   [http://www.bigcat.nl]
30. Hewett M, Oliver DE, Rubin DL, Easton KL, Stuart JM, Altman RB,
Klein TE: PharmGKB: the Pharmacogenetics Knowledge
Base.  Nucleic Acids Res 2002, 30:163-165.
31. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K,
Chetvernin V, Church DM, DiCuccio M, Edgar R, Federhen S, Geer
LY, Helmberg W, Kapustin Y, Kenton DL, Khovayko O, Lipman DJ,
Madden TL, Maglott DR, Ostell J, Pruitt KD, Schuler GD, Schriml LM,
Sequeira E, Sherry ST, Sirotkin K, Souvorov A, Starchenko G, Suzek
TO, Tatusov R, Tatusova TA, Wagner L, Yaschenko E: Database
resources of the National Center for Biotechnology Infor-
mation.  Nucleic Acids Res 2006, 34:D173-80.
32. Converting GenMAPP MAPPs between species using
homology   [http://www.genmapp.org/tutorials/Converting-MAPPs-
between-species.pdf]
33. Mao F, Su Z, Olman V, Dam P, Liu Z, Xu Y: Mapping of ortholo-
gous genes in the context of biological pathways: An applica-
tion of integer programming.  Proc Natl Acad Sci U S A 2006,
103:129-134.
34. Wu J, Mao X, Cai T, Luo J, Wei L: KOBAS server: a web-based
platform for automated annotation and pathway identifica-
tion.  Nucleic Acids Res 2006, 34:W720-4.
35. Biocarta - Charting Pathways of Life   [http://www.bio
carta.com]
36. Novak BA, Jain AN: Pathway recognition and augmentation by
computational analysis of microarray expression data.  Bioin-
formatics 2006, 22:233-241.
37. Stuart JM, Segal E, Koller D, Kim SK: A gene-coexpression net-
work for global discovery of conserved genetic modules.  Sci-
ence 2003, 302:249-255.
38. van Noort V, Snel B, Huynen MA: Predicting gene function by
conserved co-expression.  Trends Genet 2003, 19:238-242.
39. Bergmann S, Ihmels J, Barkai N: Similarities and differences in
genome-wide expression data of six organisms.  PLoS Biol 2004,
2:E9.
40. Salomonis N, Cotte N, Zambon AC, Pollard KS, Vranizan K, Doniger
SW, Dolganov G, Conklin BR: Identifying genetic networks
underlying myometrial transition to labor.  Genome Biol 2005,
6:R12.
41. Affymetrix-Exon Array Dataset   [http://www.affymetrix.com/
support/technical/sample_data/exon_array_data.affx]
42. Visualizing Multiple Color Sets   [http://www.genmapp.org/
multiple_cs.html]
43. Griffin TJ, Gygi SP, Ideker T, Rist B, Eng J, Hood L, Aebersold R:
Complementary profiling of gene expression at the tran-
scriptome and proteome levels in Saccharomyces cerevisiae.
Mol Cell Proteomics 2002, 1:323-333.
44. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer
K, Cheng S, Lindpaintner K, Samani NJ: Genotypes and haplotypes
predisposing to myocardial infarction: a multilocus case-con-
trol study.  Eur Heart J 2004, 25:459-467.
45. Cytoscape   [http://www.cytoscape.org]
46. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin
N, Schwikowski B, Ideker T: Cytoscape: a software environment
for integrated models of biomolecular interaction networks.
Genome Res 2003, 13:2498-2504.